Page last updated: 2024-09-03

cci 103f and Canine Diseases

cci 103f has been researched along with Canine Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chou, SC; Ji, X; Kleiter, MM; Lee, DY; Malarkey, DE; Raleigh, JA; Thrall, DE1
Calkins, DP; McEntee, MC; Raleigh, JA; Thrall, DE; Zeman, EM1
Cline, JM; Raleigh, JA; Rosner, GL; Thrall, DE2
Azuma, C; McEntee, MC; Raleigh, JA; Rosner, GL; Thrall, DE1
Cline, JM; Franko, AJ; Page, RL; Raleigh, JA; Thrall, DE1

Other Studies

6 other study(ies) available for cci 103f and Canine Diseases

ArticleYear
A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker.
    International journal of radiation oncology, biology, physics, 2006, Feb-01, Volume: 64, Issue:2

    Topics: Administration, Oral; Animals; Area Under Curve; Cell Hypoxia; Cell Line; Cricetinae; Cricetulus; Dog Diseases; Dogs; Feasibility Studies; Hydrogen-Ion Concentration; Injections, Intravenous; Neoplasms; Nitroimidazoles

2006
Distribution of hypoxia and proliferation associated markers in spontaneous canine tumors.
    Acta oncologica (Stockholm, Sweden), 1995, Volume: 34, Issue:3

    Topics: Animals; Biomarkers, Tumor; Biopsy; Carcinoma, Basal Cell; Cell Division; Cell Hypoxia; Dog Diseases; Dogs; Immunohistochemistry; Nitroimidazoles; Proliferating Cell Nuclear Antigen; Tumor Cells, Cultured

1995
Distribution of the hypoxia marker CCI-103F in canine tumors.
    International journal of radiation oncology, biology, physics, 1994, Mar-01, Volume: 28, Issue:4

    Topics: Animals; Cell Hypoxia; Dog Diseases; Dogs; Female; Male; Neoplasms; Nitroimidazoles

1994
Quantification of CCI-103F labeling heterogeneity in canine solid tumors.
    International journal of radiation oncology, biology, physics, 1997, Feb-01, Volume: 37, Issue:3

    Topics: Analysis of Variance; Animals; Biomarkers; Cell Hypoxia; Dog Diseases; Dogs; Neoplasms; Nitroimidazoles; Oxygen; Reproducibility of Results

1997
Hypoxia marker labeling in tumor biopsies: quantification of labeling variation and criteria for biopsy sectioning.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1997, Volume: 44, Issue:2

    Topics: Animals; Biopsy; Cell Hypoxia; Dog Diseases; Dogs; Neoplasms; Nitroimidazoles

1997
Immunohistochemical detection of a hypoxia marker in spontaneous canine tumours.
    British journal of cancer, 1990, Volume: 62, Issue:6

    Topics: Animals; Cell Hypoxia; Dog Diseases; Dogs; Immunohistochemistry; Neoplasms; Nitroimidazoles; Staining and Labeling

1990